Company Page
Most Recent Insiders Activity
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2024-10-15 | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J.
(SVP, CHIEF TECHNICAL OFFICER) |
S | Common Stock | D | 20000 | $53.26 - $54.24 | $1,070,057 |
| 2024-10-15 | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J.
(SVP, CHIEF TECHNICAL OFFICER) |
M | Common Stock | A | 20000 | $16.65 - $19.98 | $381,254 |
| 2024-10-08 | HALOZYME THERAPEUTICS, INC. | Torley Helen
(PRESIDENT AND CEO) |
S | Common Stock | D | 20000 | $51.85 - $54.57 | $1,065,740 |
| 2024-10-08 | HALOZYME THERAPEUTICS, INC. | Torley Helen
(PRESIDENT AND CEO) |
M | Common Stock | A | 20000 | $13.87 - $13.87 | $277,400 |
| 2024-09-24 | HALOZYME THERAPEUTICS, INC. | Torley Helen
(PRESIDENT AND CEO) |
S | Common Stock | D | 30000 | $56.10 - $58.21 | $1,706,440 |
| 2024-09-24 | HALOZYME THERAPEUTICS, INC. | Torley Helen
(PRESIDENT AND CEO) |
M | Common Stock | A | 30000 | $13.87 - $13.87 | $416,100 |
| 2024-09-17 | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J.
(SVP, CHIEF TECHNICAL OFFICER) |
S | Common Stock | D | 20000 | $61.89 - $62.88 | $1,249,095 |
| 2024-09-17 | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J.
(SVP, CHIEF TECHNICAL OFFICER) |
M | Common Stock | A | 20000 | $16.65 - $16.65 | $333,000 |
| 2024-09-10 | HALOZYME THERAPEUTICS, INC. | Torley Helen
(PRESIDENT AND CEO) |
S | Common Stock | D | 30000 | $59.09 - $59.20 | $1,773,790 |
| 2024-09-10 | HALOZYME THERAPEUTICS, INC. | Torley Helen
(PRESIDENT AND CEO) |
M | Common Stock | A | 30000 | $13.87 - $13.87 | $416,100 |
| 2024-08-27 | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J.
(SVP, CHIEF TECHNICAL OFFICER) |
M | Common Stock | A | 5580 | $18.41 - $18.41 | $102,727 |
| 2024-08-20 | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J.
(SVP, CHIEF TECHNICAL OFFICER) |
S | Common Stock | D | 20000 | $61.05 - $62.34 | $1,228,019 |
| 2024-08-20 | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J.
(SVP, CHIEF TECHNICAL OFFICER) |
M | Common Stock | A | 20000 | $16.65 - $16.65 | $333,000 |
| 2024-08-12 | HALOZYME THERAPEUTICS, INC. | Posard Matthew L.
(Director) |
S | Common Stock | D | 29881 | $55.72 - $57.70 | $1,689,293 |
| 2024-07-23 | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J.
(SVP, CHIEF TECHNICAL OFFICER) |
S | Common Stock | D | 20000 | $54.46 - $55.27 | $1,100,023 |
| 2024-07-23 | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J.
(SVP, CHIEF TECHNICAL OFFICER) |
M | Common Stock | A | 20000 | $8.11 - $16.65 | $232,953 |
| 2024-07-22 | HALOZYME THERAPEUTICS, INC. | LaBrosse Nicole
(SVP, CHIEF FINANCIAL OFFICER) |
S | Common Stock | D | 5000 | $53.85 - $54.25 | $269,660 |
| 2024-07-22 | HALOZYME THERAPEUTICS, INC. | LaBrosse Nicole
(SVP, CHIEF FINANCIAL OFFICER) |
M | Common Stock | A | 5000 | $22.50 - $22.50 | $112,500 |
| 2024-06-26 | HALOZYME THERAPEUTICS, INC. | LaBrosse Nicole
(SVP, CHIEF FINANCIAL OFFICER) |
S | Common Stock | D | 30000 | $51.82 - $52.04 | $1,557,940 |
| 2024-06-26 | HALOZYME THERAPEUTICS, INC. | LaBrosse Nicole
(SVP, CHIEF FINANCIAL OFFICER) |
M | Common Stock | A | 30000 | $22.50 - $22.50 | $675,000 |
| 2024-06-18 | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J.
(SVP, CHIEF TECHNICAL OFFICER) |
S | Common Stock | D | 10000 | $49.43 - $49.43 | $494,260 |
| 2024-06-18 | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J.
(SVP, CHIEF TECHNICAL OFFICER) |
M | Common Stock | A | 10000 | $8.11 - $8.11 | $81,100 |
| 2024-06-11 | HALOZYME THERAPEUTICS, INC. | Posard Matthew L.
(Director) |
S | Common Stock | D | 20000 | $50.01 - $50.62 | $1,006,300 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |